190 related articles for article (PubMed ID: 19229671)
1. Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles.
Glowka E; Sapin-Minet A; Leroy P; Lulek J; Maincent P
J Microencapsul; 2010; 27(1):25-36. PubMed ID: 19229671
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
[TBL] [Abstract][Full Text] [Related]
3. Salmon calcitonin-loaded Eudragit® and Eudragit®-PLGA nanoparticles: in vitro and in vivo evaluation.
Cetin M; Aktas MS; Vural I; Ozturk M
J Microencapsul; 2012; 29(2):156-66. PubMed ID: 22126314
[TBL] [Abstract][Full Text] [Related]
4. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
[TBL] [Abstract][Full Text] [Related]
5. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles.
Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W
Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272
[TBL] [Abstract][Full Text] [Related]
6. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
Choi SH; Park TG
Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
[TBL] [Abstract][Full Text] [Related]
7. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres.
Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM
J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486
[TBL] [Abstract][Full Text] [Related]
9. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity.
Liu J; Qiu Z; Wang S; Zhou L; Zhang S
Biomed Mater; 2010 Dec; 5(6):065002. PubMed ID: 20924138
[TBL] [Abstract][Full Text] [Related]
10. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
11. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
He W; Horn SW; Hussain MD
Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
[TBL] [Abstract][Full Text] [Related]
14. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
15. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system.
Han Y; Tian H; He P; Chen X; Jing X
Int J Pharm; 2009 Aug; 378(1-2):159-66. PubMed ID: 19465100
[TBL] [Abstract][Full Text] [Related]
16. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.
Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC
J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635
[TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of poly(DL-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation.
Yang M; Yamamoto H; Kurashima H; Takeuchi H; Yokoyama T; Tsujimoto H; Kawashima Y
Eur J Pharm Sci; 2012 Aug; 46(5):374-80. PubMed ID: 22414702
[TBL] [Abstract][Full Text] [Related]
18. Improved delivery of angiogenesis inhibitors from PLGA:poloxamer blend micro- and nanoparticles.
d'Angelo I; Parajó Y; Horváth A; Kéri G; La Rotonda MI; Alonso MJ
J Microencapsul; 2010; 27(1):57-66. PubMed ID: 19545221
[TBL] [Abstract][Full Text] [Related]
19. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M
Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres.
Dani BA; DeLuca PP
AAPS PharmSciTech; 2001 Oct; 2(4):22. PubMed ID: 14727859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
